Proactive Investors - Run By Investors For Investors

Tekcapital portfolio stalwart Belluscura raises US$1.6mln

A medical equipment specialist, Belluscura had intended to float on AIM last year
Belluscura specialises in medical equipment

Tekcapital PLC's (LON:TEK) portfolio company Belluscura PLC has raised US$1.33mln in a placing with a further US$268,000 coming in from a loan conversion.

Intellectual property specialist Tekcapital invested US$250,000 in the private placement and converted US$210,090 into equity to take its direct stake to about 39%.

READ: Tekcapital's augmented reality company Lucyd to close token sale next month

The placing was priced at US$0.18(13p) per share, giving Belluscura a post-money valuation of approximately US$3.7mln.

A medical equipment specialist, Belluscura had intended to float on AIM last year but was thwarted by tricky market conditions at the time.

Established in 2015, Belluscura has so far launched three products with two more in development.

READ: Tekcapital says investee company Belluscura decides not to proceed with planned AIM float

Money raised this time will go on the CURV oxygen concentrator and Snap III level of consciousness monitor.

Bob Rauker, Belluscura’s chief executive, said: “The funds will allow Belluscura to continue with its mission to provide premium, proprietary medical devices at affordable prices."

View full TEK profile View Profile

Tekcapital PLC Timeline

Related Articles

February 08 2018
The firm has established connections with more than 4,000 universities in 160 countries enabling it to capture all of the intellectual property available
The D3S detector kit
April 20 2018
Kromek, formerly Durham Scientific Crystals, was incorporated in April 2003 to commercialise technology that had been developed in the Physics Department of Durham University over a period of some 20 years.
Jobs market
March 13 2018
A flexible jobs market, an increase in short-term contracts - all play to the strengths of the specialist in background checks

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use